Keros Therapeutics Correlations
| KROS Stock | USD 53.84 0.30 0.55% |
The current 90-days correlation between Keros Therapeutics and Sonnet Biotherapeutics Holdings is 0.09 (i.e., Significant diversification). The correlation of Keros Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Keros Therapeutics Correlation With Market
Very weak diversification
The correlation between Keros Therapeutics and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Keros |
Moving together with Keros Stock
| 0.88 | VRDN | Viridian Therapeutics | PairCorr |
| 0.77 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.81 | PRAX | Praxis Precision Med | PairCorr |
| 0.75 | AKRO | Akero Therapeutics | PairCorr |
| 0.75 | AMLX | Amylyx Pharmaceuticals | PairCorr |
| 0.72 | SSNLF | Samsung Electronics | PairCorr |
Moving against Keros Stock
| 0.83 | VRAX | Virax Biolabs Group | PairCorr |
| 0.82 | BDRX | Biodexa Pharmaceticals Upward Rally | PairCorr |
| 0.78 | DYN | Dyne Therapeutics | PairCorr |
| 0.59 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.57 | KURA | Kura Oncology | PairCorr |
| 0.54 | VRPX | Virpax Pharmaceuticals | PairCorr |
| 0.54 | REVB | Revelation Biosciences | PairCorr |
| 0.48 | XFOR | X4 Pharmaceuticals | PairCorr |
| 0.39 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.39 | STOK | Stoke Therapeutics | PairCorr |
| 0.38 | PALI | Palisade Bio | PairCorr |
| 0.37 | LGVN | Longeveron LLC | PairCorr |
| 0.33 | INZY | Inozyme Pharma | PairCorr |
| 0.32 | KALV | Kalvista Pharmaceuticals | PairCorr |
| 0.32 | KPRX | Kiora Pharmaceuticals | PairCorr |
| 0.31 | KTTA | Pasithea Therapeutics | PairCorr |
| 0.51 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.44 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.4 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.39 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.33 | PPERY | Bank Mandiri Persero | PairCorr |
Related Correlations Analysis
| 0.68 | -0.08 | 0.34 | -0.19 | -0.05 | ZVSA | ||
| 0.68 | 0.03 | 0.55 | -0.22 | -0.02 | SONN | ||
| -0.08 | 0.03 | 0.25 | 0.54 | 0.29 | ZURA | ||
| 0.34 | 0.55 | 0.25 | 0.14 | -0.14 | PHIO | ||
| -0.19 | -0.22 | 0.54 | 0.14 | -0.03 | RNAZ | ||
| -0.05 | -0.02 | 0.29 | -0.14 | -0.03 | QNRX | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Keros Stock performing well and Keros Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Keros Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
| SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
| ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
| PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
| RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
| QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Keros Therapeutics Corporate Management
| Robin Wagner | Senior Resources | Profile | |
| Simon MBBS | Chief Officer | Profile | |
| Keith MBA | Chief Officer | Profile | |
| Christopher MSc | Chief Officer | Profile | |
| John MBA | Senior Management | Profile | |
| Jennifer Lachey | Chief Officer | Profile | |
| Jasbir Seehra | CEO and President | Profile |